← back to search

Michael A. Gillette

Academia Sinica · TW
Area of research
Cancer Research · Spectroscopy
Research interest
Research interests include Advanced Proteomics Techniques and Applications, Cancer Genomics and Diagnostics, Cancer, Lipids, and Metabolism, and Ubiquitin and proteasome pathways.
h-index
51
citations
76,582
works
200
NIH funding
primary concept
Medicine
email

Recent publications

Precision proteogenomics reveals pan-cancer impact of germline variants
Cell 2025cited by 6position: middledoi
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Cancer Cell 2025cited by 5position: middledoi
Pan-cancer proteogenomics characterization of tumor immunity
Cell 2024cited by 84position: middledoi
Comprehensive proteogenomic characterization of rare kidney tumors
Cell Reports Medicine 2024cited by 44position: middledoi
Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Cell 2023cited by 179position: middledoi
Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Cancer Cell 2023cited by 100position: middledoi
Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cell 2023cited by 99position: middledoi
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues
Nature Communications 2023cited by 57position: middledoi
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Scientific Reports 2023cited by 46position: middledoi
Deep learning integrates histopathology and proteogenomics at a pan-cancer level
Cell Reports Medicine 2023cited by 31position: middledoi
Cancer proteogenomics: current impact and future prospects
Nature reviews. Cancer 2022cited by 207position: middledoi
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
Cancer Discovery 2022cited by 133position: middledoi
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cell 2021cited by 584position: middledoi
A proteogenomic portrait of lung squamous cell carcinoma
Cell 2021cited by 384position: middledoi
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Cancer Cell 2021cited by 376position: middledoi
Abstract P065: Proteogenomic characterization of CDK4/6 inhibitor-resistant ER+ breast cancer
Molecular Cancer Therapeutics 2021cited by 0position: middledoi
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell 2020cited by 810position: firstdoi
Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
Cell 2020cited by 546position: middledoi
Integrated Proteomic and Glycoproteomic Characterization of Human High-Grade Serous Ovarian Carcinoma
Cell Reports 2020cited by 154position: middledoi
Microscaled proteogenomic methods for precision oncology
Nature Communications 2020cited by 120position: middledoi
Biomarkers to Distinguish Bacterial From Viral Pediatric Clinical Pneumonia in a Malaria-Endemic Setting
Clinical Infectious Diseases 2020cited by 20position: firstdoi
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Cell 2019cited by 837position: middledoi
A rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough
Science Translational Medicine 2019cited by 68position: lastdoi
Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
Nature Protocols 2018cited by 526position: middledoi
A Curated Resource for Phosphosite-specific Signature Analysis
Molecular & Cellular Proteomics 2018cited by 359position: middledoi
Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups
Cancer Cell 2018cited by 214position: middledoi
Proteogenomic integration reveals therapeutic targets in breast cancer xenografts
Nature Communications 2017cited by 153position: middledoi
Proteogenomics connects somatic mutations to signalling in breast cancer
Nature 2016cited by 1,748position: middledoi
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Cell 2016cited by 1,100position: middledoi
Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array
Clinical Cancer Research 2015cited by 97position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven A. Carr · Broad Institute8 papers (2012–2023)Karen C. Albright · SUNY Upstate Medical University4 papers (2012–2014)Andre Kumar · Palo Alto University4 papers (2012–2014)D.R. Mani · Broad Institute4 papers (2018–2023)James E. Siegler · University of Chicago4 papers (2012–2014)Sheryl Martin‐Schild · University of New Orleans4 papers (2012–2014)Shankha Satpathy · Broad Institute3 papers (2021–2023)Steven J. Skates · Harvard University3 papers (2013–2023)Amelia K. Boehme · Engineering Information Foundation3 papers (2012–2012)Ronny Drapkin · Merseburg University of Applied Sciences2 papers (2015–2023) · 2 papers (2015–2020)Jill P. Mesirov · University of California San Diego2 papers (2015–2018)Quique Bassat · BorgWarner (Brazil)2 papers (2015–2020)Michael J. Birrer · University of Arkansas at Little Rock2 papers (2015–2023)Karl R. Clauser · Broad Institute2 papers (2022–2023)Dyann F. Wirth · Broad Institute2 papers (2015–2020)T. Mark Beasley · University of Alabama at Birmingham2 papers (2012–2014)Pedro L. Alonso · Universidad de Las Palmas de Gran Canaria2 papers (2015–2020)Lola Madrid · London School of Hygiene & Tropical Medicine2 papers (2015–2020)Rushdy Ahmad · Massachusetts Institute of Technology2 papers (2015–2018)